Eric Lefebvre - 21 Mar 2022 Form 4 Insider Report for CymaBay Therapeutics, Inc. (CBAY)

Role
Director
Signature
/s/ Paul Quinlan, as attorney-in-fact for Eric Lefebvre
Issuer symbol
CBAY
Transactions as of
21 Mar 2022
Transactions value $
$0
Form type
4
Filing time
21 Mar 2022, 17:40:56 UTC
Previous filing
02 Feb 2022
Next filing
13 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBAY Stock Option (right to buy) Award $0 +115K $0.00 115K 21 Mar 2022 Common Stock 115K $3.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/36 of the underlying shares monthly from March 21, 2022.